The contribution of growth hormone to mammary neoplasia

Journal of Mammary Gland Biology and Neoplasia

Volumn 13, Issue 1, 2008, Pages 131-145

  Perry, Jo K ^a   Mohankumar, Kumarasamypet M ^b   Emerald, B Starling ^a   Mertani, Hichem C ^c   Lobie, Peter E ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b THE UNIVERSITY OF AUCKLAND   (New Zealand)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

Breast cancer; Growth hormone; Mammary development

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTIESTROGEN; ANTINEOPLASTIC AGENT; AROMATASE INHIBITOR; ESTROGEN; G 120R; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR RECEPTOR ANTAGONIST; HOMEODOMAIN PROTEIN; HORMONE RECEPTOR BLOCKING AGENT; HUMAN GROWTH HORMONE; MITOMYCIN C; PEGVISOMANT; PROGESTERONE; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ACROMEGALY; ADVANCED CANCER; ANTHROPOMETRY; APOPTOSIS; AUTOCRINE EFFECT; BREAST CANCER; BREAST DEVELOPMENT; BREAST HYPERPLASIA; CANCER CELL; CANCER GROWTH; CANCER INCIDENCE; CANCER INHIBITION; CANCER MORTALITY; CANCER RESISTANCE; CANCER RISK; CELL ACTIVATION; CELL DIFFERENTIATION; CELL GROWTH; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL TRIAL; CORRELATIONAL STUDY; DRUG EFFICACY; DRUG MECHANISM; EPIGENETICS; GENE EXPRESSION REGULATION; GENETIC RISK; GROWTH HORMONE DEFICIENCY; HORMONE ACTION; HORMONE DETERMINATION; HORMONE RELEASE; HUMAN; MALIGNANT TRANSFORMATION; MONOTHERAPY; MUTATIONAL ANALYSIS; NONHUMAN; ONCOGENE; PHENOTYPE; POINT MUTATION; PROTEIN EXPRESSION; PROTEIN SECRETION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION; STEM CELL; TUMOR VASCULARIZATION;

EID: 40249118235     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10911-008-9070-z     Document Type: Review

References (146)

1. 1. DS Salomon MT Lewis 2004 Embryogenesis and oncogenesis: Dr Jekyll and Mr Hyde J Mammary Gland Biol Neoplasia 9 2 105 107 15300006 Salomon DS, Lewis MT. Embryogenesis and oncogenesis: Dr Jekyll and Mr Hyde. J Mammary Gland Biol Neoplasia 2004;9(2):105–7.
2. 2. MD Sternlicht 2006 Key stages in mammary gland development: the cues that regulate ductal branching morphogenesis Breast Cancer Res 8 1 201 16524451 Sternlicht MD. Key stages in mammary gland development: the cues that regulate ductal branching morphogenesis. Breast Cancer Res 2006;8(1):201.
3. 3. DL Kleinberg 1997 Early mammary development: growth hormone and IGF-1 J Mammary Gland Biol Neoplasia 2 1 49 57 10887519 1:STN:280:DC%2BD3czksFOgsw%3D%3D Kleinberg DL. Early mammary development: growth hormone and IGF-1. J Mammary Gland Biol Neoplasia 1997;2(1):49–57.
4. 4. D Roith Le C Bondy S Yakar JL Liu A Butler 2001 The somatomedin hypothesis: 2001 Endocr Rev 22 1 53 74 11159816 Le Roith D, Bondy C, Yakar S, Liu JL, Butler A. The somatomedin hypothesis: 2001. Endocr Rev 2001;22(1):53–74.
5. 5. T Zhu EL Goh R Graichen L Ling PE Lobie 2001 Signal transduction via the growth hormone receptor Cell Signal 13 9 599 616 11495718 1:CAS:528:DC%2BD3MXlslGntL0%3D Zhu T, Goh EL, Graichen R, Ling L, Lobie PE. Signal transduction via the growth hormone receptor. Cell Signal 2001;13(9):599–616.
6. 6. J Russo IH Russo 2006 The role of estrogen in the initiation of breast cancer J Steroid Biochem Mol Biol 102 1–5 89 96 17113977 1:CAS:528:DC%2BD28Xht1CmtL%2FN Russo J, Russo IH. The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol 2006;102(1–5):89–96.
7. 7. CV Clevenger PA Furth SE Hankinson LA Schuler 2003 The role of prolactin in mammary carcinoma Endocr Rev 24 1 1 27 12588805 1:CAS:528:DC%2BD3sXhslOgsb8%3D Clevenger CV, Furth PA, Hankinson SE, Schuler LA. The role of prolactin in mammary carcinoma. Endocr Rev 2003;24(1):1–27.
8. 8. H Wennbo J Tornell 2000 The role of prolactin and growth hormone in breast cancer Oncogene 19 8 1072 1076 10713692 1:CAS:528:DC%2BD3cXitVegsrw%3D Wennbo H, Tornell J. The role of prolactin and growth hormone in breast cancer. Oncogene 2000;19(8):1072–6.
9. 9. C Laban SA Bustin PJ Jenkins 2003 The GH-IGF-I axis and breast cancer Trends Endocrinol Metab 14 1 28 34 12475609 1:CAS:528:DC%2BD38XptlWnur8%3D Laban C, Bustin SA, Jenkins PJ. The GH-IGF-I axis and breast cancer. Trends Endocrinol Metab 2003;14(1):28–34.
10. 10. JK Perry BS Emerald HC Mertani PE Lobie 2006 The oncogenic potential of growth hormone Growth Horm IGF Res 16 5–6 277 289 17101287 1:CAS:528:DC%2BD28Xht1eqtLbE Perry JK, Emerald BS, Mertani HC, Lobie PE. The oncogenic potential of growth hormone. Growth Horm IGF Res 2006;16(5–6):277–89.
11. 11. R Luft H Olivecrona B Sjogren 1952 Hypophysectomy in man Nord Med 47 11 351 354 14929443 1:STN:280:DyaG38%2FlvFGmsQ%3D%3D Luft R, Olivecrona H, Sjogren B. Hypophysectomy in man. Nord Med 1952;47(11):351–4.
12. 12. BS Ray OH Pearson 1962 Hypophysectomy in treatment of disseminated breast cancer Surg Clin North Am 42 419 433 14490693 1:STN:280:DyaF38%2Fpt1antQ%3D%3D Ray BS, Pearson OH. Hypophysectomy in treatment of disseminated breast cancer. Surg Clin North Am 1962;42:419–33.
13. 13. MJ Waters JL Barclay 2007 Does growth hormone drive breast and other cancers? Endocrinology 148 10 4533 4535 17876033 1:CAS:528:DC%2BD2sXhtFWls73O Waters MJ, Barclay JL. Does growth hormone drive breast and other cancers? Endocrinology 2007;148(10):4533–5.
14. 14. YH Ibrahim D Yee 2005 Insulin-like growth factor-I and breast cancer therapy Clin Cancer Res 11 2 Pt 2 944s 950s 15701891 1:CAS:528:DC%2BD2MXislWnsrc%3D Ibrahim YH, Yee D. Insulin-like growth factor-I and breast cancer therapy. Clin Cancer Res 2005;11(2 Pt 2):944s–50s.
15. 15. PA Kelly S Ali M Rozakis L Goujon M Nagano I Pellegrini 1993 The growth hormone/prolactin receptor family Recent Prog Horm Res 48 123 164 8441846 1:CAS:528:DyaK3sXks1ehsr0%3D Kelly PA, Ali S, Rozakis M, Goujon L, Nagano M, Pellegrini I, et al. The growth hormone/prolactin receptor family. Recent Prog Horm Res 1993;48:123–64.
16. 16. KK Kaulsay HC Mertani J Tornell G Morel KO Lee PE Lobie 1999 Autocrine stimulation of human mammary carcinoma cell proliferation by human growth hormone Exp Cell Res 250 1 35 50 10388519 1:CAS:528:DyaK1MXktV2ksLc%3D Kaulsay KK, Mertani HC, Tornell J, Morel G, Lee KO, Lobie PE. Autocrine stimulation of human mammary carcinoma cell proliferation by human growth hormone. Exp Cell Res 1999;250(1):35–50.
17. 17. KK Kaulsay T Zhu W Bennett KO Lee PE Lobie 2001 The effects of autocrine human growth hormone (hGH) on human mammary carcinoma cell behavior are mediated via the hGH receptor Endocrinology 142 2 767 777 11159849 1:CAS:528:DC%2BD3MXhtFSrt7w%3D Kaulsay KK, Zhu T, Bennett W, Lee KO, Lobie PE. The effects of autocrine human growth hormone (hGH) on human mammary carcinoma cell behavior are mediated via the hGH receptor. Endocrinology 2001;142(2):767–77.
18. 18. S Mukhina HC Mertani K Guo KO Lee PD Gluckman PE Lobie 2004 Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone Proc Natl Acad Sci USA 101 42 15166 15171 15353581 1:CAS:528:DC%2BD2cXpsVSgsbY%3D Mukhina S, Mertani HC, Guo K, Lee KO, Gluckman PD, Lobie PE. Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone. Proc Natl Acad Sci USA 2004;101(42):15166–71.
19. 19. XQ Xu BS Emerald EL Goh N Kannan LD Miller PD Gluckman 2005 Gene expression profiling to identify oncogenic determinants of autocrine human growth hormone in human mammary carcinoma J Biol Chem 280 25 23987 24003 15845533 1:CAS:528:DC%2BD2MXltlKhurY%3D Xu XQ, Emerald BS, Goh EL, Kannan N, Miller LD, Gluckman PD, et al. Gene expression profiling to identify oncogenic determinants of autocrine human growth hormone in human mammary carcinoma. J Biol Chem 2005;280(25):23987–4003.
20. 20. T Zhu B Starling-Emerald X Zhang KO Lee PD Gluckman HC Mertani 2005 Oncogenic transformation of human mammary epithelial cells by autocrine human growth hormone Cancer Res 65 1 317 324 15665309 1:CAS:528:DC%2BD2MXhvFamuw%3D%3D Zhu T, Starling-Emerald B, Zhang X, Lee KO, Gluckman PD, Mertani HC, et al. Oncogenic transformation of human mammary epithelial cells by autocrine human growth hormone. Cancer Res 2005;65(1):317–24.
21. 21. Z Zhu S Mukhina T Zhu HC Mertani KO Lee PE Lobie 2005 p44/42 MAP kinase-dependent regulation of catalase by autocrine human growth hormone protects human mammary carcinoma cells from oxidative stress-induced apoptosis Oncogene 24 23 3774 3785 15782123 1:CAS:528:DC%2BD2MXksVOjs70%3D Zhu Z, Mukhina S, Zhu T, Mertani HC, Lee KO, Lobie PE. p44/42 MAP kinase-dependent regulation of catalase by autocrine human growth hormone protects human mammary carcinoma cells from oxidative stress-induced apoptosis. Oncogene 2005;24(23):3774–85.
22. 22. BS Emerald Y Chen T Zhu Z Zhu KO Lee PD Gluckman 2007 AlphaCP1 mediates stabilization of hTERT mRNA by autocrine human growth hormone J Biol Chem 282 1 680 690 17085453 1:CAS:528:DC%2BD2sXkslen Emerald BS, Chen Y, Zhu T, Zhu Z, Lee KO, Gluckman PD, et al. AlphaCP1 mediates stabilization of hTERT mRNA by autocrine human growth hormone. J Biol Chem 2007;282(1):680–90.
23. 23. PD Walden W Ruan M Feldman DL Kleinberg 1998 Evidence that the mammary fat pad mediates the action of growth hormone in mammary gland development Endocrinology 139 2 659 662 9449638 1:CAS:528:DyaK1cXns12muw%3D%3D Walden PD, Ruan W, Feldman M, Kleinberg DL. Evidence that the mammary fat pad mediates the action of growth hormone in mammary gland development. Endocrinology 1998;139(2):659–62.
24. 24. S Mukhina D Liu K Guo M Raccurt S Borges-Bendris HC Mertani 2006 Autocrine growth hormone prevents lactogenic differentiation of mouse mammary epithelial cells Endocrinology 147 4 1819 1829 16423870 1:CAS:528:DC%2BD28Xjt1Oht7k%3D Mukhina S, Liu D, Guo K, Raccurt M, Borges-Bendris S, Mertani HC, et al. Autocrine growth hormone prevents lactogenic differentiation of mouse mammary epithelial cells. Endocrinology 2006;147(4):1819–29.
25. 25. MI Gallego N Binart GW Robinson R Okagaki KT Coschigano J Perry 2001 Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects Dev Biol 229 1 163 175 11133161 1:CAS:528:DC%2BD3cXptVygt7k%3D Gallego MI, Binart N, Robinson GW, Okagaki R, Coschigano KT, Perry J, et al. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects. Dev Biol 2001;229(1):163–75.
26. 26. J Divisova I Kuiatse Z Lazard H Weiss F Vreeland DL Hadsell 2006 The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth Breast Cancer Res Treat 98 315 327 16541323 1:CAS:528:DC%2BD28XnvVGmu7k%3D Divisova J, Kuiatse I, Lazard Z, Weiss H, Vreeland F, Hadsell DL, et al. The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth. Breast Cancer Res Treat 2006;98:315–27.
27. 27. SM Swanson TG Unterman 2002 The growth hormone-deficient spontaneous dwarf rat is resistant to chemically induced mammary carcinogenesis Carcinogenesis 23 6 977 982 12082019 1:CAS:528:DC%2BD38Xlt1Knurw%3D Swanson SM, Unterman TG. The growth hormone-deficient spontaneous dwarf rat is resistant to chemically induced mammary carcinogenesis. Carcinogenesis 2002;23(6):977–82.
28. 28. JA Mol SC Henzen-Logmans P Hageman W Misdorp MA Blankenstein A Rijnberk 1995 Expression of the gene encoding growth hormone in the human mammary gland J Clin Endocrinol Metab 80 10 3094 3096 7559904 1:CAS:528:DyaK2MXoslCntrc%3D Mol JA, Henzen-Logmans SC, Hageman P, Misdorp W, Blankenstein MA, Rijnberk A. Expression of the gene encoding growth hormone in the human mammary gland. J Clin Endocrinol Metab 1995;80(10):3094–6.
29. 29. M Raccurt PE Lobie E Moudilou T Garcia-Caballero L Frappart G Morel 2002 High stromal and epithelial human gh gene expression is associated with proliferative disorders of the mammary gland J Endocrinol 175 2 307 318 12429029 1:CAS:528:DC%2BD38Xptlaktb4%3D Raccurt M, Lobie PE, Moudilou E, Garcia-Caballero T, Frappart L, Morel G, et al. High stromal and epithelial human gh gene expression is associated with proliferative disorders of the mammary gland. J Endocrinol 2002;175(2):307–18.
30. 30. O Bchini AC Andres B Schubaur M Mehtali M LeMeur R Lathe 1991 Precocious mammary gland development and milk protein synthesis in transgenic mice ubiquitously expressing human growth hormone Endocrinology 128 1 539 546 1986943 1:CAS:528:DyaK3MXpsFekuw%3D%3D 10.1210/endo-128-1-539 Bchini O, Andres AC, Schubaur B, Mehtali M, LeMeur M, Lathe R, et al. Precocious mammary gland development and milk protein synthesis in transgenic mice ubiquitously expressing human growth hormone. Endocrinology 1991;128(1):539–46.
31. 31. H Nagasawa Y Noguchi T Mori K Niki H Namiki 1985 Suppression of normal and preneoplastic mammary growth and uterine adenomyosis with reduced growth hormone level in SHN mice given monosodium glutamate neonatally Eur J Cancer Clin Oncol 21 12 1547 1551 3830732 1:CAS:528:DyaL28Xms1yisg%3D%3D Nagasawa H, Noguchi Y, Mori T, Niki K, Namiki H. Suppression of normal and preneoplastic mammary growth and uterine adenomyosis with reduced growth hormone level in SHN mice given monosodium glutamate neonatally. Eur J Cancer Clin Oncol 1985;21(12):1547–51.
32. 32. HC Mertani T Garcia-Caballero A Lambert F Gerard C Palayer JM Boutin 1998 Cellular expression of growth hormone and prolactin receptors in human breast disorders Int J Cancer 79 2 202 211 9583737 1:CAS:528:DyaK1MXksl2ku70%3D Mertani HC, Garcia-Caballero T, Lambert A, Gerard F, Palayer C, Boutin JM, et al. Cellular expression of growth hormone and prolactin receptors in human breast disorders. Int J Cancer 1998;79(2):202–11.
33. 33. HC Mertani MC Delehaye-Zervas JF Martini MC Postel-Vinay G Morel 1995 Localization of growth hormone receptor messenger RNA in human tissues Endocrine 3 135 142 1:CAS:528:DyaK2MXksV2lt7s%3D 10.1007/BF02990065 Mertani HC, Delehaye-Zervas MC, Martini JF, Postel-Vinay MC, Morel G. Localization of growth hormone receptor messenger RNA in human tissues. Endocrine 1995;3:135–142.
34. 34. DP Rose M Gottardis JJ Noonan 1983 Rat mammary carcinoma regressions during suppression of serum growth hormone and prolactin Anticancer Res 3 5 323 325 6139974 1:CAS:528:DyaL2cXksFKmsA%3D%3D Rose DP, Gottardis M, Noonan JJ. Rat mammary carcinoma regressions during suppression of serum growth hormone and prolactin. Anticancer Res 1983;3(5):323–5.
35. 35. JA Mol E Garderen van GR Rutteman A Rijnberk 1996 New insights in the molecular mechanism of progestin-induced proliferation of mammary epithelium: induction of the local biosynthesis of growth hormone (GH) in the mammary glands of dogs, cats and humans J Steroid Biochem Mol Biol 57 1–2 67 71 8645618 1:CAS:528:DyaK28XjtVegt7c%3D Mol JA, van Garderen E, Rutteman GR, Rijnberk A. New insights in the molecular mechanism of progestin-induced proliferation of mammary epithelium: induction of the local biosynthesis of growth hormone (GH) in the mammary glands of dogs, cats and humans. J Steroid Biochem Mol Biol 1996;57(1–2):67–71.
36. 36. A Rijnberk HS Kooistra JA Mol 2003 Endocrine diseases in dogs and cats: similarities and differences with endocrine diseases in humans Growth Horm IGF Res 13 Suppl A S158 S164 12914747 1:CAS:528:DC%2BD3sXmt1Khtb0%3D Rijnberk A, Kooistra HS, Mol JA. Endocrine diseases in dogs and cats: similarities and differences with endocrine diseases in humans. Growth Horm IGF Res 2003;13(Suppl A):S158–64.
37. 37. JA Mol E Garderen van PJ Selman J Wolfswinkel A Rijinberk GR Rutteman 1995 Growth hormone mRNA in mammary gland tumors of dogs and cats J Clin Invest 95 5 2028 2034 7738169 1:CAS:528:DyaK2MXltlWrtrs%3D Mol JA, van Garderen E, Selman PJ, Wolfswinkel J, Rijinberk A, Rutteman GR. Growth hormone mRNA in mammary gland tumors of dogs and cats. J Clin Invest 1995;95(5):2028–34.
38. 38. ST Ng J Zhou OO Adesanya J Wang D LeRoith CA Bondy 1997 Growth hormone treatment induces mammary gland hyperplasia in aging primates Nat Med 3 10 1141 1144 9334728 1:CAS:528:DyaK2sXmsF2it7c%3D Ng ST, Zhou J, Adesanya OO, Wang J, LeRoith D, Bondy CA. Growth hormone treatment induces mammary gland hyperplasia in aging primates. Nat Med 1997;3(10):1141–4.
39. 39. XF Yang WG Beamer H Huynh M Pollak 1996 Reduced growth of human breast cancer xenografts in hosts homozygous for the lit mutation Cancer Res 56 7 1509 1511 8603394 1:CAS:528:DyaK28XitVemsLo%3D Yang XF, Beamer WG, Huynh H, Pollak M. Reduced growth of human breast cancer xenografts in hosts homozygous for the lit mutation. Cancer Res 1996;56(7):1509–11.
40. 40. G Thordarson S Semaan C Low D Ochoa H Leong L Rajkumar 2004 Mammary tumorigenesis in growth hormone deficient spontaneous dwarf rats; effects of hormonal treatments Breast Cancer Res Treat 87 3 277 290 15528971 1:CAS:528:DC%2BD2cXptlSlu78%3D Thordarson G, Semaan S, Low C, Ochoa D, Leong H, Rajkumar L, et al. Mammary tumorigenesis in growth hormone deficient spontaneous dwarf rats; effects of hormonal treatments. Breast Cancer Res Treat 2004;87(3):277–90.
41. 41. MM Ramsey RL Ingram AB Cashion AH Ng JM Cline AF Parlow 2002 Growth hormone-deficient dwarf animals are resistant to dimethylbenzanthracine (DMBA)-induced mammary carcinogenesis Endocrinology 143 10 4139 4142 12239127 1:CAS:528:DC%2BD38Xnt1ygtL0%3D Ramsey MM, Ingram RL, Cashion AB, Ng AH, Cline JM, Parlow AF, et al. Growth hormone-deficient dwarf animals are resistant to dimethylbenzanthracine (DMBA)-induced mammary carcinogenesis. Endocrinology 2002;143(10):4139–42.
42. 42. Q Shen DD Lantvit Q Lin Y Li K Christov Z Wang 2007 Advanced rat mammary cancers are growth hormone dependent Endocrinology 148 10 4536 4544 17584969 1:CAS:528:DC%2BD2sXhtFWls73P Shen Q, Lantvit DD, Lin Q, Li Y, Christov K, Wang Z, et al. Advanced rat mammary cancers are growth hormone dependent. Endocrinology 2007;148(10):4536–44.
43. 43. X Zhang RG Mehta DD Lantvit KT Coschigano JJ Kopchick JE Green 2007 Inhibition of estrogen-independent mammary carcinogenesis by disruption of growth hormone signaling Carcinogenesis 28 1 143 150 16916863 Zhang X, Mehta RG, Lantvit DD, Coschigano KT, Kopchick JJ, Green JE, et al. Inhibition of estrogen-independent mammary carcinogenesis by disruption of growth hormone signaling. Carcinogenesis 2007;28(1):143–50.
44. 44. IG Maroulakou M Anver L Garrett JE Green 1994 Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene Proc Natl Acad Sci USA 91 23 11236 11240 7972041 1:CAS:528:DyaK2MXitV2rtb8%3D Maroulakou IG, Anver M, Garrett L, Green JE. Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. Proc Natl Acad Sci USA 1994;91(23):11236–40.
45. 45. M Pollak MJ Blouin JC Zhang JJ Kopchick 2001 Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist Br J Cancer 85 3 428 430 11487276 1:CAS:528:DC%2BD3MXmslSgt7o%3D Pollak M, Blouin MJ, Zhang JC, Kopchick JJ. Reduced mammary gland carcinogenesis in transgenic mice expressing a growth hormone antagonist. Br J Cancer 2001;85(3):428–30.
46. 46. J Tornell B Carlsson P Pohjanen H Wennbo L Rymo O Isaksson 1992 High frequency of mammary adenocarcinomas in metallothionein promoter-human growth hormone transgenic mice created from two different strains of mice J Steroid Biochem Mol Biol 43 1–3 237 242 1525063 1:STN:280:DyaK38zpvFejtw%3D%3D Tornell J, Carlsson B, Pohjanen P, Wennbo H, Rymo L, Isaksson O. High frequency of mammary adenocarcinomas in metallothionein promoter-human growth hormone transgenic mice created from two different strains of mice. J Steroid Biochem Mol Biol 1992;43(1–3):237–42.
47. 47. H Wennbo M Gebre-Medhin A Gritli-Linde C Ohlsson OG Isaksson J Tornell 1997 Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice J Clin Invest 100 11 2744 2751 9389738 1:CAS:528:DyaK2sXotVaqsL4%3D Wennbo H, Gebre-Medhin M, Gritli-Linde A, Ohlsson C, Isaksson OG, Tornell J. Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. J Clin Invest 1997;100(11):2744–51.
48. 48. L Marchand Le T Donlon A Seifried R Kaaks S Rinaldi LR Wilkens 2002 Association of a common polymorphism in the human GH1 gene with colorectal neoplasia J Natl Cancer Inst 94 6 454 460 11904318 Le Marchand L, Donlon T, Seifried A, Kaaks R, Rinaldi S, Wilkens LR. Association of a common polymorphism in the human GH1 gene with colorectal neoplasia. J Natl Cancer Inst 2002;94(6):454–60.
49. 49. K Wagner K Hemminki A Forsti 2007 The GH1/IGF-1 axis polymorphisms and their impact on breast cancer development Breast Cancer Res Treat 104 3 233 248 17082888 1:CAS:528:DC%2BD2sXoslGht7c%3D Wagner K, Hemminki K, Forsti A. The GH1/IGF-1 axis polymorphisms and their impact on breast cancer development. Breast Cancer Res Treat 2007;104(3):233–48.
50. 50. PJ Jenkins 2004 Acromegaly and cancer Horm Res 62 Suppl 1 108 115 15761242 1:CAS:528:DC%2BD2MXitFOltLY%3D Jenkins PJ. Acromegaly and cancer. Horm Res 2004;62(Suppl 1):108–15.
51. 51. O Shevah Z Laron 2007 Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: a preliminary report Growth Horm IGF Res 17 1 54 57 17166755 1:CAS:528:DC%2BD2sXitl2iurw%3D Shevah O, Laron Z. Patients with congenital deficiency of IGF-I seem protected from the development of malignancies: a preliminary report. Growth Horm IGF Res 2007;17(1):54–7.
52. 52. KB Michels F Xue 2006 Role of birthweight in the etiology of breast cancer Int J Cancer 119 2007 2025 16823839 1:CAS:528:DC%2BD28XhtVSks7bL Michels KB, Xue F. Role of birthweight in the etiology of breast cancer. Int J Cancer 2006;119:2007–25.
53. 53. M Ahlgren M Melbye J Wohlfahrt TI Sorensen 2006 Growth patterns and the risk of breast cancer in women Int J Gynecol Cancer 16 Suppl 2 569 575 17010075 Ahlgren M, Melbye M, Wohlfahrt J, Sorensen TI. Growth patterns and the risk of breast cancer in women. Int J Gynecol Cancer 2006;16(Suppl 2):569–75.
54. 54. BL Stavola De I dos Santos Silva V McCormack RJ Hardy DJ Kuh ME Wadsworth 2004 Childhood growth and breast cancer Am J Epidemiol 159 7 671 682 15033645 De Stavola BL, dos Santos Silva I, McCormack V, Hardy RJ, Kuh DJ, Wadsworth ME. Childhood growth and breast cancer. Am J Epidemiol 2004;159(7):671–82.
55. 55. D Gunnell M Okasha GD Smith SE Oliver J Sandhu JM Holly 2001 Height, leg length, and cancer risk: a systematic review Epidemiol Rev 23 2 313 342 12192740 1:STN:280:DC%2BD38vjsFGltw%3D%3D Gunnell D, Okasha M, Smith GD, Oliver SE, Sandhu J, Holly JM. Height, leg length, and cancer risk: a systematic review. Epidemiol Rev 2001;23(2):313–42.
56. 56. E Lundqvist J Kaprio PK Verkasalo E Pukkala M Koskenvuo KC Soderberg 2007 Co-twin control and cohort analyses of body mass index and height in relation to breast, prostate, ovarian, corpus uteri, colon and rectal cancer among Swedish and Finnish twins Int J Cancer 121 4 810 818 17455257 1:CAS:528:DC%2BD2sXotlequrg%3D Lundqvist E, Kaprio J, Verkasalo PK, Pukkala E, Koskenvuo M, Soderberg KC, et al. Co-twin control and cohort analyses of body mass index and height in relation to breast, prostate, ovarian, corpus uteri, colon and rectal cancer among Swedish and Finnish twins. Int J Cancer 2007;121(4):810–8.
57. 57. F Waard de JH Thijssen 2005 Hormonal aspects in the causation of human breast cancer: epidemiological hypotheses reviewed, with special reference to nutritional status and first pregnancy J Steroid Biochem Mol Biol 97 5 451 458 16230007 de Waard F, Thijssen JH. Hormonal aspects in the causation of human breast cancer: epidemiological hypotheses reviewed, with special reference to nutritional status and first pregnancy. J Steroid Biochem Mol Biol 2005;97(5):451–8.
58. 58. L Sivaraman D Medina 2002 Hormone-induced protection against breast cancer J Mammary Gland Biol Neoplasia 7 1 77 92 12160088 Sivaraman L, Medina D. Hormone-induced protection against breast cancer. J Mammary Gland Biol Neoplasia 2002;7(1):77–92.
59. 59. G Thordarson E Jin RC Guzman SM Swanson S Nandi F Talamantes 1995 Refractoriness to mammary tumorigenesis in parous rats: is it caused by persistent changes in the hormonal environment or permanent biochemical alterations in the mammary epithelia? Carcinogenesis 16 11 2847 2853 7586208 1:CAS:528:DyaK2MXpslCnsb8%3D Thordarson G, Jin E, Guzman RC, Swanson SM, Nandi S, Talamantes F. Refractoriness to mammary tumorigenesis in parous rats: is it caused by persistent changes in the hormonal environment or permanent biochemical alterations in the mammary epithelia? Carcinogenesis 1995;16(11):2847–53.
60. 60. J Russo R Moral GA Balogh D Mailo IH Russo 2005 The protective role of pregnancy in breast cancer Breast Cancer Res 7 3 131 142 15987443 Russo J, Moral R, Balogh GA, Mailo D, Russo IH. The protective role of pregnancy in breast cancer. Breast Cancer Res 2005;7(3):131–42.
61. 61. C Ginestier MS Wicha 2007 Mammary stem cell number as a determinate of breast cancer risk Breast Cancer Res 9 4 109 17688678 Ginestier C, Wicha MS. Mammary stem cell number as a determinate of breast cancer risk. Breast Cancer Res 2007;9(4):109.
62. 62. TM Savarese WC Strohsnitter HP Low Q Liu I Baik W Okulicz 2007 Correlation of umbilical cord blood hormones and growth factors with stem cell potential: implications for the prenatal origin of breast cancer hypothesis Breast Cancer Res 9 3 R29 17501995 Savarese TM, Strohsnitter WC, Low HP, Liu Q, Baik I, Okulicz W, et al. Correlation of umbilical cord blood hormones and growth factors with stem cell potential: implications for the prenatal origin of breast cancer hypothesis. Breast Cancer Res 2007;9(3):R29.
63. 63. CM Blakely AJ Stoddard GK Belka KD Dugan KL Notarfrancesco SE Moody 2006 Hormone-induced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancy Cancer Res 66 12 6421 6431 16778221 1:CAS:528:DC%2BD28XlvVSrsrg%3D Blakely CM, Stoddard AJ, Belka GK, Dugan KD, Notarfrancesco KL, Moody SE, et al. Hormone-induced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancy. Cancer Res 2006;66(12):6421–31.
64. 64. H Markkanen T Pekkarinen MJ Valimaki H Alfthan R Kauppinen-Makelin T Sane 2006 Effect of sex and assay method on serum concentrations of growth hormone in patients with acromegaly and in healthy controls Clin Chem 52 3 468 473 16439607 1:CAS:528:DC%2BD28Xit1ShtLo%3D Markkanen H, Pekkarinen T, Valimaki MJ, Alfthan H, Kauppinen-Makelin R, Sane T, et al. Effect of sex and assay method on serum concentrations of growth hormone in patients with acromegaly and in healthy controls. Clin Chem 2006;52(3):468–73.
65. 65. JT Emerman M Leahy PW Gout N Bruchovsky 1985 Elevated growth hormone levels in sera from breast cancer patients Horm Metab Res 17 8 421 424 4054832 1:STN:280:DyaL28%2FjtFOkug%3D%3D Emerman JT, Leahy M, Gout PW, Bruchovsky N. Elevated growth hormone levels in sera from breast cancer patients. Horm Metab Res 1985;17(8):421–4.
66. 66. S Yakar D Leroith P Brodt 2005 The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models Cytokine Growth Factor Rev 16 4–5 407 420 15886048 1:CAS:528:DC%2BD2MXmvVCnu70%3D Yakar S, Leroith D, Brodt P. The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: Lessons from animal models. Cytokine Growth Factor Rev 2005;16(4–5):407–20.
67. 67. HM Khandwala IE McCutcheon A Flyvbjerg KE Friend 2000 The effects of insulin-like growth factors on tumorigenesis and neoplastic growth Endocr Rev 21 3 215 244 10857553 1:CAS:528:DC%2BD3cXlsF2gt7w%3D Khandwala HM, McCutcheon IE, Flyvbjerg A, Friend KE. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 2000;21(3):215–44.
68. 68. RR Love DR Rose TS Surawicz PA Newcomb 1991 Prolactin and growth hormone levels in premenopausal women with breast cancer and healthy women with a strong family history of breast cancer Cancer 68 6 1401 1405 1873792 1:STN:280:DyaK3MzjvFWhtA%3D%3D Love RR, Rose DR, Surawicz TS, Newcomb PA. Prolactin and growth hormone levels in premenopausal women with breast cancer and healthy women with a strong family history of breast cancer. Cancer 1991;68(6):1401–5.
69. 69. K Pazaitou-Panayiotou T Kelesidis I Kelesidis A Kaprara J Blakeman I Vainas 2007 Growth hormone-binding protein is directly and IGFBP-3 is inversely associated with risk of female breast cancer Eur J Endocrinol 156 2 187 194 17287408 1:CAS:528:DC%2BD2sXntlyqu7o%3D Pazaitou-Panayiotou K, Kelesidis T, Kelesidis I, Kaprara A, Blakeman J, Vainas I, et al. Growth hormone-binding protein is directly and IGFBP-3 is inversely associated with risk of female breast cancer. Eur J Endocrinol 2007;156(2):187–94.
70. 70. G Baumann 2002 Growth hormone binding protein. The soluble growth hormone receptor Minerva Endocrinol 27 4 265 276 12511849 1:STN:280:DC%2BD3s%2FgsFyksQ%3D%3D Baumann G. Growth hormone binding protein. The soluble growth hormone receptor. Minerva Endocrinol 2002;27(4):265–76.
71. 71. K Wagner K Hemminki E Israelsson E Grzybowska R Klaes B Chen 2005 Association of polymorphisms and haplotypes in the human growth hormone 1 (GH1) gene with breast cancer Endocr Relat Cancer 12 4 917 928 16322331 1:CAS:528:DC%2BD28XnvVyisg%3D%3D Wagner K, Hemminki K, Israelsson E, Grzybowska E, Klaes R, Chen B, et al. Association of polymorphisms and haplotypes in the human growth hormone 1 (GH1) gene with breast cancer. Endocr Relat Cancer 2005;12(4):917–28.
72. 72. M Horan DS Millar J Hedderich G Lewis V Newsway N Mo 2003 Human growth hormone 1 (GH1) gene expression: complex haplotype-dependent influence of polymorphic variation in the proximal promoter and locus control region Hum Mutat 21 4 408 423 12655556 1:CAS:528:DC%2BD3sXjtFKrur8%3D Horan M, Millar DS, Hedderich J, Lewis G, Newsway V, Mo N, et al. Human growth hormone 1 (GH1) gene expression: complex haplotype-dependent influence of polymorphic variation in the proximal promoter and locus control region. Hum Mutat 2003;21(4):408–23.
73. 73. K Wagner K Hemminki E Grzybowska JL Bermejo D Butkiewicz J Pamula 2006 Polymorphisms in the growth hormone receptor: a case-control study in breast cancer Int J Cancer 118 11 2903 2906 16381017 1:CAS:528:DC%2BD28Xks1Sitr8%3D Wagner K, Hemminki K, Grzybowska E, Bermejo JL, Butkiewicz D, Pamula J, et al. Polymorphisms in the growth hormone receptor: a case-control study in breast cancer. Int J Cancer 2006;118(11):2903–6.
74. 74. K Wagner K Hemminki E Grzybowska R Klaes B Burwinkel P Bugert 2006 Polymorphisms in genes involved in GH1 release and their association with breast cancer risk Carcinogenesis 27 9 1867 1875 16606630 1:CAS:528:DC%2BD28Xotl2msLk%3D Wagner K, Hemminki K, Grzybowska E, Klaes R, Burwinkel B, Bugert P, et al. Polymorphisms in genes involved in GH1 release and their association with breast cancer risk. Carcinogenesis 2006;27(9):1867–75.
75. 75. F Canzian JD McKay RJ Cleveland L Dossus C Biessy C Boillot 2005 Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study Cancer Epidemiol Biomark Prev 14 10 2316 2325 1:CAS:528:DC%2BD2MXhtVymt7vM Canzian F, McKay JD, Cleveland RJ, Dossus L, Biessy C, Boillot C, et al. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study. Cancer Epidemiol Biomark Prev 2005;14(10):2316–25.
76. 76. C Mulhall RA Hegele H Cao D Tritchler M Yaffe NF Boyd 2005 Pituitary growth hormone and growth hormone-releasing hormone receptor genes and associations with mammographic measures and serum growth hormone Cancer Epidemiol Biomark Prev 14 11 Pt 1 2648 2654 1:CAS:528:DC%2BD2MXhtlWhu77N Mulhall C, Hegele RA, Cao H, Tritchler D, Yaffe M, Boyd NF. Pituitary growth hormone and growth hormone-releasing hormone receptor genes and associations with mammographic measures and serum growth hormone. Cancer Epidemiol Biomark Prev 2005;14(11 Pt 1):2648–54.
77. 77. PJ Jenkins A Mukherjee SM Shalet 2006 Does growth hormone cause cancer? Clin Endocrinol (Oxf) 64 2 115 121 1:STN:280:DC%2BD28%2Fkt1yrsg%3D%3D Jenkins PJ, Mukherjee A, Shalet SM. Does growth hormone cause cancer? Clin Endocrinol (Oxf) 2006;64(2):115–21.
78. 78. I Banerjee PE Clayton 2007 Growth hormone treatment and cancer risk Endocrinol Metab Clin N Am 36 1 247 263 1:CAS:528:DC%2BD2sXkslKhu78%3D Banerjee I, Clayton PE. Growth hormone treatment and cancer risk. Endocrinol Metab Clin N Am 2007;36(1):247–63.
79. 79. MM Rutter SR Rose 2007 Long-term endocrine sequelae of childhood cancer Curr Opin Pediatr 19 4 480 487 17630615 Rutter MM, Rose SR. Long-term endocrine sequelae of childhood cancer. Curr Opin Pediatr 2007;19(4):480–7.
80. 80. T Maneatis J Baptista K Connelly S Blethen 2000 Growth hormone safety update from the National Cooperative Growth Study J Pediatr Endocrinol Metab 13 Suppl 2 1035 1044 11086659 Maneatis T, Baptista J, Connelly K, Blethen S. Growth hormone safety update from the National Cooperative Growth Study. J Pediatr Endocrinol Metab 2000;13(Suppl 2):1035–44.
81. 81. D Wyatt 2004 Lessons from the national cooperative growth study Eur J Endocrinol 151 Suppl 1 S55 S59 15339245 1:CAS:528:DC%2BD2cXotlKjtLY%3D Wyatt D. Lessons from the national cooperative growth study. Eur J Endocrinol 2004;151(Suppl 1):S55–9.
82. 82. JP Neglia DL Friedman Y Yasui AC Mertens S Hammond M Stovall 2001 Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study J Natl Cancer Inst 93 8 618 629 11309438 1:STN:280:DC%2BD3M3hvFejtA%3D%3D Neglia JP, Friedman DL, Yasui Y, Mertens AC, Hammond S, Stovall M, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Natl Cancer Inst 2001;93(8):618–29.
83. 83. AJ Swerdlow CD Higgins P Adlard MA Preece 2002 Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959–85: a cohort study Lancet 360 9329 273 277 12147369 1:CAS:528:DC%2BD38XlvVSms7s%3D Swerdlow AJ, Higgins CD, Adlard P, Preece MA. Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959–85: a cohort study. Lancet 2002;360(9329):273–7.
84. 84. B Ergun-Longmire AC Mertens P Mitby J Qin G Heller W Shi 2006 Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor J Clin Endocrinol Metab 91 9 3494 3498 16822820 1:CAS:528:DC%2BD28Xpslajtb0%3D Ergun-Longmire B, Mertens AC, Mitby P, Qin J, Heller G, Shi W, et al. Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J Clin Endocrinol Metab 2006;91(9):3494–8.
85. 85. CA Sklar AC Mertens P Mitby G Occhiogrosso J Qin G Heller 2002 Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study J Clin Endocrinol Metab 87 7 3136 3141 12107213 1:CAS:528:DC%2BD38XlsVGjt7s%3D Sklar CA, Mertens AC, Mitby P, Occhiogrosso G, Qin J, Heller G, et al. Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 2002;87(7):3136–41.
86. 86. A Kaganowicz NH Farkouh AG Frantz AU Blaustein 1979 Ectopic human growth hormone in ovaries and breast cancer J Clin Endocrinol Metab 48 1 5 8 422705 1:STN:280:DyaE1M7jtVOjsg%3D%3D 10.1210/jcem-48-1-5 Kaganowicz A, Farkouh NH, Frantz AG, Blaustein AU. Ectopic human growth hormone in ovaries and breast cancer. J Clin Endocrinol Metab 1979;48(1):5–8.
87. 87. H Jammes P Gaye L Belair J Djiane 1991 Identification and characterization of growth hormone receptor mRNA in the mammary gland Mol Cell Endocrinol 75 1 27 35 1675612 1:CAS:528:DyaK3MXpsFCiuw%3D%3D Jammes H, Gaye P, Belair L, Djiane J. Identification and characterization of growth hormone receptor mRNA in the mammary gland. Mol Cell Endocrinol 1991;75(1):27–35.
88. 88. C Decouvelaere JP Peyrat J Bonneterre J Djiane H Jammes 1995 Presence of the two growth hormone receptor messenger RNA isoforms in human breast cancer Cell Growth Differ 6 4 477 483 7794815 1:CAS:528:DyaK2MXkvFWks78%3D Decouvelaere C, Peyrat JP, Bonneterre J, Djiane J, Jammes H. Presence of the two growth hormone receptor messenger RNA isoforms in human breast cancer. Cell Growth Differ 1995;6(4):477–83.
89. 89. M Gebre-Medhin LG Kindblom H Wennbo J Tornell JM Meis-Kindblom 2001 Growth hormone receptor is expressed in human breast cancer Am J Pathol 158 4 1217 1222 11290538 1:CAS:528:DC%2BD3MXjtVWhsLs%3D Gebre-Medhin M, Kindblom LG, Wennbo H, Tornell J, Meis-Kindblom JM. Growth hormone receptor is expressed in human breast cancer. Am J Pathol 2001;158(4):1217–22.
90. 90. I Chatzistamou AV Schally H Kiaris E Politi J Varga G Kanellis 2004 Immunohistochemical detection of GHRH and its receptor splice variant 1 in primary human breast cancers Eur J Endocrinol 151 3 391 396 15362970 1:CAS:528:DC%2BD2cXot1Khtrw%3D Chatzistamou I, Schally AV, Kiaris H, Politi E, Varga J, Kanellis G, et al. Immunohistochemical detection of GHRH and its receptor splice variant 1 in primary human breast cancers. Eur J Endocrinol 2004;151(3):391–6.
91. 91. Z Kahan JM Arencibia VJ Csernus K Groot RD Kineman WR Robinson 1999 Expression of growth hormone-releasing hormone (GHRH) messenger ribonucleic acid and the presence of biologically active GHRH in human breast, endometrial, and ovarian cancers J Clin Endocrinol Metab 84 2 582 589 10022420 1:CAS:528:DyaK1MXhtVCitLY%3D Kahan Z, Arencibia JM, Csernus VJ, Groot K, Kineman RD, Robinson WR, et al. Expression of growth hormone-releasing hormone (GHRH) messenger ribonucleic acid and the presence of biologically active GHRH in human breast, endometrial, and ovarian cancers. J Clin Endocrinol Metab 1999;84(2):582–9.
92. 92. AV Schally JL Varga 2006 Antagonists of growth hormone-releasing hormone in oncology Comb Chem High Throughput Screen 9 3 163 170 16533148 1:CAS:528:DC%2BD28XisVSqtLk%3D Schally AV, Varga JL. Antagonists of growth hormone-releasing hormone in oncology. Comb Chem High Throughput Screen 2006;9(3):163–70.
93. 93. C Gil-Puig S Seoane M Blanco M Macia T Garcia-Caballero C Segura 2005 Pit-1 is expressed in normal and tumorous human breast and regulates GH secretion and cell proliferation Eur J Endocrinol 153 2 335 344 16061841 1:CAS:528:DC%2BD2MXpslOhsLw%3D Gil-Puig C, Seoane S, Blanco M, Macia M, Garcia-Caballero T, Segura C, et al. Pit-1 is expressed in normal and tumorous human breast and regulates GH secretion and cell proliferation. Eur J Endocrinol 2005;153(2):335–44.
94. 94. IS Lantinga-van Leeuwen M Oudshoorn JA Mol 1999 Canine mammary growth hormone gene transcription initiates at the pituitary-specific start site in the absence of Pit-1 Mol Cell Endocrinol 150 1–2 121 128 10411306 1:CAS:528:DyaK1MXjtFWltr4%3D Lantinga-van Leeuwen IS, Oudshoorn M, Mol JA. Canine mammary growth hormone gene transcription initiates at the pituitary-specific start site in the absence of Pit-1. Mol Cell Endocrinol 1999;150(1–2):121–8.
95. 95. DR Green GI Evan 2002 A matter of life and death Cancer Cell 1 1 19 30 12086884 1:CAS:528:DC%2BD38XitlCmsLc%3D Green DR, Evan GI. A matter of life and death. Cancer Cell 2002;1(1):19–30.
96. 96. D Hanahan RA Weinberg 2000 The hallmarks of cancer Cell 100 1 57 70 10647931 1:CAS:528:DC%2BD3cXks1CktA%3D%3D Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100(1):57–70.
97. 97. HC Mertani T Zhu EL Goh KO Lee G Morel PE Lobie 2001 Autocrine human growth hormone (hGH) regulation of human mammary carcinoma cell gene expression. Identification of CHOP as a mediator of hGH-stimulated human mammary carcinoma cell survival J Biol Chem 276 24 21464 21475 11297545 1:CAS:528:DC%2BD3MXksFGlurk%3D Mertani HC, Zhu T, Goh EL, Lee KO, Morel G, Lobie PE. Autocrine human growth hormone (hGH) regulation of human mammary carcinoma cell gene expression. Identification of CHOP as a mediator of hGH-stimulated human mammary carcinoma cell survival. J Biol Chem 2001;276(24):21464–75.
98. 98. G Dimri H Band V Band 2005 Mammary epithelial cell transformation: insights from cell culture and mouse models Breast Cancer Res 7 4 171 179 15987472 1:CAS:528:DC%2BD2MXls1GjtLg%3D Dimri G, Band H, Band V. Mammary epithelial cell transformation: insights from cell culture and mouse models. Breast Cancer Res 2005;7(4):171–9.
99. 99. SA Stewart RA Weinberg 2006 Telomeres: cancer to human aging Annu Rev Cell Dev Biol 22 531 557 16824017 1:CAS:528:DC%2BD28Xht1yjs7jE Stewart SA, Weinberg RA. Telomeres: cancer to human aging. Annu Rev Cell Dev Biol 2006;22:531–57.
100. 100. L Gomez-Garcia FM Sanchez MT Vallejo-Cremades IA Segura de M Campo Ede del 2005 Direct activation of telomerase by GH via phosphatidylinositol 3′-kinase J Endocrinol 185 3 421 428 15930168 1:CAS:528:DC%2BD2MXlsFeqtrg%3D Gomez-Garcia L, Sanchez FM, Vallejo-Cremades MT, de Segura IA, del Campo Ede M. Direct activation of telomerase by GH via phosphatidylinositol 3′-kinase. J Endocrinol 2005;185(3):421–8.
101. 101. J Debnath SK Muthuswamy JS Brugge 2003 Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures Methods 30 3 256 268 12798140 1:CAS:528:DC%2BD3sXkt1OqurY%3D Debnath J, Muthuswamy SK, Brugge JS. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 2003;30(3):256–68.
102. 102. OW Petersen L Ronnov-Jessen AR Howlett MJ Bissell 1992 Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells Proc Natl Acad Sci USA 89 19 9064 9068 1384042 1:STN:280:DyaK3s%2FivVCjtw%3D%3D Petersen OW, Ronnov-Jessen L, Howlett AR, Bissell MJ. Interaction with basement membrane serves to rapidly distinguish growth and differentiation pattern of normal and malignant human breast epithelial cells. Proc Natl Acad Sci USA 1992;89(19):9064–8.
103. 103. MJ Bissell A Rizki IS Mian 2003 Tissue architecture: the ultimate regulator of breast epithelial function Curr Opin Cell Biol 15 6 753 762 14644202 1:CAS:528:DC%2BD3sXptlyksL8%3D Bissell MJ, Rizki A, Mian IS. Tissue architecture: the ultimate regulator of breast epithelial function. Curr Opin Cell Biol 2003;15(6):753–62.
104. 104. J Debnath KR Mills NL Collins MJ Reginato SK Muthuswamy JS Brugge 2002 The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini Cell 111 1 29 40 12372298 1:CAS:528:DC%2BD38XnvFCrtb8%3D Debnath J, Mills KR, Collins NL, Reginato MJ, Muthuswamy SK, Brugge JS. The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 2002;111(1):29–40.
105. 105. T Jacks RA Weinberg 2002 Taking the study of cancer cell survival to a new dimension Cell 111 7 923 925 12507419 1:CAS:528:DC%2BD3sXis1KjtQ%3D%3D Jacks T, Weinberg RA. Taking the study of cancer cell survival to a new dimension. Cell 2002;111(7):923–5.
106. 106. CL Sommers SW Byers EW Thompson JA Torri EP Gelmann 1994 Differentiation state and invasiveness of human breast cancer cell lines Breast Cancer Res Treat 31 2–3 325 335 7881109 1:STN:280:DyaK2M7os1yisw%3D%3D Sommers CL, Byers SW, Thompson EW, Torri JA, Gelmann EP. Differentiation state and invasiveness of human breast cancer cell lines. Breast Cancer Res Treat 1994;31(2–3):325–35.
107. 107. JP Thiery 2002 Epithelial-mesenchymal transitions in tumour progression Nat Rev Cancer 2 6 442 454 12189386 1:CAS:528:DC%2BD38Xksl2ltr8%3D Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002;2(6):442–54.
108. 108. S Banerjee M Dowsett A Ashworth LA Martin 2007 Mechanisms of disease: angiogenesis and the management of breast cancer Nat Clin Pract Oncol 4 9 536 550 17728712 1:CAS:528:DC%2BD2sXps12msrs%3D Banerjee S, Dowsett M, Ashworth A, Martin LA. Mechanisms of disease: angiogenesis and the management of breast cancer. Nat Clin Pract Oncol 2007;4(9):536–50.
109. 109. J Lawler M Detmar 2004 Tumor progression: the effects of thrombospondin-1 and-2 Int J Biochem Cell Biol 36 6 1038 1045 15094119 1:CAS:528:DC%2BD2cXjt1ant70%3D Lawler J, Detmar M. Tumor progression: the effects of thrombospondin-1 and-2. Int J Biochem Cell Biol 2004;36(6):1038–45.
110. 110. M Hongo T Ryoke J Schoenfeld J Hunter N Dalton R Clark 2000 Effects of growth hormone on cardiac dysfunction and gene expression in genetic murine dilated cardiomyopathy Basic Res Cardiol 95 6 431 441 11192363 1:CAS:528:DC%2BD3MXktFCitA%3D%3D Hongo M, Ryoke T, Schoenfeld J, Hunter J, Dalton N, Clark R, et al. Effects of growth hormone on cardiac dysfunction and gene expression in genetic murine dilated cardiomyopathy. Basic Res Cardiol 2000;95(6):431–41.
111. 111. A Cittadini J Isgaard MG Monti C Casaburi A Gianni Di R Serpico 2003 Growth hormone prolongs survival in experimental postinfarction heart failure J Am Coll Cardiol 41 12 2154 2163 12821240 1:CAS:528:DC%2BD3sXnvVSqsLY%3D Cittadini A, Isgaard J, Monti MG, Casaburi C, Di Gianni A, Serpico R, et al. Growth hormone prolongs survival in experimental postinfarction heart failure. J Am Coll Cardiol 2003;41(12):2154–63.
112. 112. J Gould C Aramburo M Capdevielle CG Scanes 1995 Angiogenic activity of anterior pituitary tissue and growth hormone on the chick embryo chorio-allantoic membrane: a novel action of GH Life Sci 56 8 587 594 7532777 1:CAS:528:DyaK2MXjtFKqs7Y%3D Gould J, Aramburo C, Capdevielle M, Scanes CG. Angiogenic activity of anterior pituitary tissue and growth hormone on the chick embryo chorio-allantoic membrane: a novel action of GH. Life Sci 1995;56(8):587–94.
113. 113. A Colao C Somma Di MC Savanelli M Leo De G Lombardi 2006 Beginning to end: cardiovascular implications of growth hormone (GH) deficiency and GH therapy Growth Horm IGF Res 16 Suppl A S41 S48 16690338 1:CAS:528:DC%2BD28Xmt1Grtb8%3D Colao A, Di Somma C, Savanelli MC, De Leo M, Lombardi G. Beginning to end: cardiovascular implications of growth hormone (GH) deficiency and GH therapy. Growth Horm IGF Res 2006;16(Suppl A):S41–8.
114. 114. T Thum J Bauersachs 2006 Growth hormone regulates vascular function—what we know from bench and bedside Growth Horm IGF Res 62 29 32 1:CAS:528:DC%2BD28XhslCjs78%3D Thum T, Bauersachs J. Growth hormone regulates vascular function—what we know from bench and bedside. Growth Horm IGF Res 2006;62:29–32.
115. 115. PH Oomen JA Beentjes E Bosma AJ Smit WD Reitsma RP Dullaart 2002 Reduced capillary permeability and capillary density in the skin of GH-deficient adults: improvement after 12 months GH replacement Clin Endocrinol (Oxf) 56 4 519 524 1:CAS:528:DC%2BD38XjvFOjurw%3D Oomen PH, Beentjes JA, Bosma E, Smit AJ, Reitsma WD, Dullaart RP. Reduced capillary permeability and capillary density in the skin of GH-deficient adults: improvement after 12 months GH replacement. Clin Endocrinol (Oxf) 2002;56(4):519–24.
116. 116. K Kusano Y Tsutsumi J Dean M Gavin H Ma M Silver 2007 Long-term stable expression of human growth hormone by rAAV promotes myocardial protection post-myocardial infarction J Mol Cell Cardiol 42 2 390 399 17174322 1:CAS:528:DC%2BD2sXhtVKls7w%3D Kusano K, Tsutsumi Y, Dean J, Gavin M, Ma H, Silver M, et al. Long-term stable expression of human growth hormone by rAAV promotes myocardial protection post-myocardial infarction. J Mol Cell Cardiol 2007;42(2):390–9.
117. 117. JK Jameel VS Rao L Cawkwell PJ Drew 2004 Radioresistance in carcinoma of the breast Breast 13 6 452 460 15563851 1:STN:280:DC%2BD2crptFSitw%3D%3D Jameel JK, Rao VS, Cawkwell L, Drew PJ. Radioresistance in carcinoma of the breast. Breast 2004;13(6):452–60.
118. 118. P Wardman 2007 Chemical radiosensitizers for use in radiotherapy Clin Oncol (R Coll Radiol) 19 6 397 417 1:STN:280:DC%2BD2szpsVSltg%3D%3D Wardman P. Chemical radiosensitizers for use in radiotherapy. Clin Oncol (R Coll Radiol) 2007;19(6):397–417.
119. 119. X Wu M Wan G Li Z Xu C Chen F Liu 2006 Growth hormone receptor overexpression predicts response of rectal cancers to pre-operative radiotherapy Eur J Cancer 42 7 888 894 16516462 1:CAS:528:DC%2BD28XksVOitLc%3D Wu X, Wan M, Li G, Xu Z, Chen C, Liu F, et al. Growth hormone receptor overexpression predicts response of rectal cancers to pre-operative radiotherapy. Eur J Cancer 2006;42(7):888–94.
120. 120. N Liu HC Mertani G Norstedt J Tornell PE Lobie 1997 Mode of the autocrine/paracrine mechanism of growth hormone action Exp Cell Res 237 1 196 206 9417883 1:CAS:528:DyaK2sXnvFWlsr0%3D Liu N, Mertani HC, Norstedt G, Tornell J, Lobie PE. Mode of the autocrine/paracrine mechanism of growth hormone action. Exp Cell Res 1997;237(1):196–206.
121. 121. MP Wajnrajch 2005 Physiological and pathological growth hormone secretion J Pediatr Endocrinol Metab 18 4 325 338 15844466 1:CAS:528:DC%2BD2MXjvVymsr8%3D Wajnrajch MP. Physiological and pathological growth hormone secretion. J Pediatr Endocrinol Metab 2005;18(4):325–38.
122. 122. HW Davey RJ Wilkins DJ Waxman 1999 STAT5 signaling in sexually dimorphic gene expression and growth patterns Am J Hum Genet 65 4 959 965 10486314 1:STN:280:DC%2BD3cvnsFertg%3D%3D Davey HW, Wilkins RJ, Waxman DJ. STAT5 signaling in sexually dimorphic gene expression and growth patterns. Am J Hum Genet 1999;65(4):959–65.
123. 123. RD York H Yao T Dillon CL Ellig SP Eckert EW McCleskey 1998 Rap1 mediates sustained MAP kinase activation induced by nerve growth factor Nature 392 6676 622 626 9560161 1:CAS:528:DyaK1cXis1Wjtrs%3D York RD, Yao H, Dillon T, Ellig CL, Eckert SP, McCleskey EW, et al. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature 1998;392(6676):622–6.
124. 124. T Zhu L Ling PE Lobie 2002 Identification of a JAK2-independent pathway regulating growth hormone (GH)-stimulated p44/42 mitogen-activated protein kinase activity. GH activation of Ral and phospholipase D is Src-dependent J Biol Chem 277 47 45592 45603 12218045 1:CAS:528:DC%2BD38Xosl2ksbo%3D Zhu T, Ling L, Lobie PE. Identification of a JAK2-independent pathway regulating growth hormone (GH)-stimulated p44/42 mitogen-activated protein kinase activity. GH activation of Ral and phospholipase D is Src-dependent. J Biol Chem 2002;277(47):45592–603.
125. 125. R Graichen D Liu Y Sun KO Lee PE Lobie 2002 Autocrine human growth hormone inhibits placental transforming growth factor-beta gene transcription to prevent apoptosis and allow cell cycle progression of human mammary carcinoma cells J Biol Chem 277 29 26662 26672 11994274 1:CAS:528:DC%2BD38XlsFKqs7s%3D Graichen R, Liu D, Sun Y, Lee KO, Lobie PE. Autocrine human growth hormone inhibits placental transforming growth factor-beta gene transcription to prevent apoptosis and allow cell cycle progression of human mammary carcinoma cells. J Biol Chem 2002;277(29):26662–72.
126. 126. Madsen J, Nielsen O, Tornoe I, Thim L, Holmskov U. Tissue localization of human trefoil factor 1, 2, and 3. J Histochem Cytochem 2007 (in press).
127. 127. G Regalo NA Wright JC Machado 2005 Trefoil factors: from ulceration to neoplasia Cell Mol Life Sci 62 24 2910 2915 16374578 1:CAS:528:DC%2BD28Xms1GktQ%3D%3D Regalo G, Wright NA, Machado JC. Trefoil factors: from ulceration to neoplasia. Cell Mol Life Sci 2005;62(24):2910–5.
128. 128. Perry JK, Kannan N, Grandison PM, Mitchell MD, Lobie PE. Are trefoil factors oncogenic? Trends Endocrinol Metab 2007 (in press).
129. 129. X Zhang T Zhu Y Chen HC Mertani KO Lee PE Lobie 2003 Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene J Biol Chem 278 9 7580 7590 12482855 1:CAS:528:DC%2BD3sXhsVKitbk%3D Zhang X, Zhu T, Chen Y, Mertani HC, Lee KO, Lobie PE. Human growth hormone-regulated HOXA1 is a human mammary epithelial oncogene. J Biol Chem 2003;278(9):7580–90.
130. 130. KM Mohankumar XQ Xu T Zhu N Kannan LD Miller ET Liu 2007 HOXA1-stimulated oncogenicity is mediated by selective upregulation of components of the p44/42 MAP kinase pathway in human mammary carcinoma cells Oncogene 26 27 3998 4008 17213808 1:CAS:528:DC%2BD2sXmtFeqs70%3D Mohankumar KM, Xu XQ, Zhu T, Kannan N, Miller LD, Liu ET, et al. HOXA1-stimulated oncogenicity is mediated by selective upregulation of components of the p44/42 MAP kinase pathway in human mammary carcinoma cells. Oncogene 2007;26(27):3998–4008.
131. 131. JP Issa 2007 DNA methylation as a therapeutic target in cancer Clin Cancer Res 13 6 1634 1637 17363514 1:CAS:528:DC%2BD2sXivV2gtr8%3D Issa JP. DNA methylation as a therapeutic target in cancer. Clin Cancer Res 2007;13(6):1634–7.
132. 132. Shafiei F, Rahnama L, Pawella L, Mitchell MD, Gluckman PD, Lobie PE. DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells. Oncogene 2007 (in press).
133. 133. S Melmed 2006 Medical progress: acromegaly N Engl J Med 355 24 2558 2573 17167139 1:CAS:528:DC%2BD28XhtlWqsbzK Melmed S. Medical progress: acromegaly. N Engl J Med 2006;355(24):2558–73.
134. 134. G Tachas S Lofthouse CJ Wraight BF Baker NB Sioufi RA Jarres 2006 A GH receptor antisense oligonucleotide inhibits hepatic GH receptor expression, IGF-I production and body weight gain in normal mice J Endocrinol 189 1 147 154 16614389 1:CAS:528:DC%2BD28Xkslaqtrs%3D Tachas G, Lofthouse S, Wraight CJ, Baker BF, Sioufi NB, Jarres RA, et al. A GH receptor antisense oligonucleotide inhibits hepatic GH receptor expression, IGF-I production and body weight gain in normal mice. J Endocrinol 2006;189(1):147–54.
135. 135. S Okada JJ Kopchick 2001 Biological effects of growth hormone and its antagonist Trends Mol Med 7 3 126 132 11286784 1:CAS:528:DC%2BD3MXivVGlsL4%3D Okada S, Kopchick JJ. Biological effects of growth hormone and its antagonist. Trends Mol Med 2001;7(3):126–32.
136. 136. A Colao R Pivonello RS Auriemma M Galdiero E Guerra F Milone 2005 New perspectives in the medical treatment of acromegaly J Endocrinol Invest 28 11 Suppl 58 66 16625847 1:STN:280:DC%2BD283hvV2rtg%3D%3D Colao A, Pivonello R, Auriemma RS, Galdiero M, Guerra E, Milone F, et al. New perspectives in the medical treatment of acromegaly. J Endocrinol Invest 2005;28(11 Suppl):58–66.
137. 137. F Dagnaes-Hansen H Duan LM Rasmussen KE Friend A Flyvbjerg 2004 Growth hormone receptor antagonist administration inhibits growth of human colorectal carcinoma in nude mice Anticancer Res 24 6 3735 3742 15736405 1:CAS:528:DC%2BD2MXitFyls78%3D Dagnaes-Hansen F, Duan H, Rasmussen LM, Friend KE, Flyvbjerg A. Growth hormone receptor antagonist administration inhibits growth of human colorectal carcinoma in nude mice. Anticancer Res 2004;24(6):3735–42.
138. 138. KE Friend R Radinsky IE McCutcheon 1999 Growth hormone receptor expression and function in meningiomas: effect of a specific receptor antagonist J Neurosurg 91 1 93 99 10389886 1:CAS:528:DyaK1MXktleqs7c%3D Friend KE, Radinsky R, McCutcheon IE. Growth hormone receptor expression and function in meningiomas: effect of a specific receptor antagonist. J Neurosurg 1999;91(1):93–9.
139. 139. IE McCutcheon A Flyvbjerg H Hill J Li WF Bennett JA Scarlett 2001 Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice J Neurosurg 94 3 487 492 11235955 1:CAS:528:DC%2BD3MXhvFKgtbc%3D McCutcheon IE, Flyvbjerg A, Hill H, Li J, Bennett WF, Scarlett JA, et al. Antitumor activity of the growth hormone receptor antagonist pegvisomant against human meningiomas in nude mice. J Neurosurg 2001;94(3):487–92.
140. 140. KE Friend 2001 Cancer and the potential place for growth hormone receptor antagonist therapy Growth Horm IGF Res 11 Suppl A S121 S123 11527083 Friend KE. Cancer and the potential place for growth hormone receptor antagonist therapy. Growth Horm IGF Res 2001;11(Suppl A):S121–3.
141. 141. G Fuh P Colosi WI Wood JA Wells 1993 Mechanism-based design of prolactin receptor antagonists J Biol Chem 268 8 5376 5381 8449901 1:CAS:528:DyaK3sXhvVelu7o%3D Fuh G, Colosi P, Wood WI, Wells JA. Mechanism-based design of prolactin receptor antagonists. J Biol Chem 1993;268(8):5376–81.
142. 142. A Stangelberger AV Schally M Zarandi E Heinrich K Groot A Havt 2007 The combination of antagonists of LHRH with antagonists of GHRH improves inhibition of androgen sensitive MDA-PCa-2b and LuCaP-35 prostate cancers Prostate 67 12 1339 1353 17624923 1:CAS:528:DC%2BD2sXhtFGgtLbK Stangelberger A, Schally AV, Zarandi M, Heinrich E, Groot K, Havt A, et al. The combination of antagonists of LHRH with antagonists of GHRH improves inhibition of androgen sensitive MDA-PCa-2b and LuCaP-35 prostate cancers. Prostate 2007;67(12):1339–53.
143. 143. CA Kanashiro AV Schally M Zarandi BD Hammann JL Varga 2007 Alterations of EGFR/HER, angiogenesis and apoptosis pathways after therapy with antagonists of growth hormone releasing hormone and bombesin in non-small cell lung cancer Int J Oncol 30 4 1019 1028 17332943 1:CAS:528:DC%2BD2sXkt1Whtbk%3D Kanashiro CA, Schally AV, Zarandi M, Hammann BD, Varga JL. Alterations of EGFR/HER, angiogenesis and apoptosis pathways after therapy with antagonists of growth hormone releasing hormone and bombesin in non-small cell lung cancer. Int J Oncol 2007;30(4):1019–28.
144. 144. S Buchholz AV Schally JB Engel F Hohla E Heinrich F Koester 2007 Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel Proc Natl Acad Sci USA 104 6 1943 1946 17261802 1:CAS:528:DC%2BD2sXitVejs7c%3D Buchholz S, Schally AV, Engel JB, Hohla F, Heinrich E, Koester F, et al. Potentiation of mammary cancer inhibition by combination of antagonists of growth hormone-releasing hormone with docetaxel. Proc Natl Acad Sci USA 2007;104(6):1943–6.
145. 145. F Hohla AV Schally K Szepeshazi JL Varga S Buchholz F Koster 2006 Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormone-releasing hormone in combination with docetaxel Proc Natl Acad Sci USA 103 39 14513 14518 16983095 1:CAS:528:DC%2BD28XhtVOgtr3N Hohla F, Schally AV, Szepeshazi K, Varga JL, Buchholz S, Koster F, et al. Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormone-releasing hormone in combination with docetaxel. Proc Natl Acad Sci USA 2006;103(39):14513–8.
146. 146. S Senan EF Smit 2007 Design of clinical trials of radiation combined with antiangiogenic therapy Oncologist 12 4 465 477 17470689 1:CAS:528:DC%2BD2sXmtlSitrc%3D Senan S, Smit EF. Design of clinical trials of radiation combined with antiangiogenic therapy. Oncologist 2007;12(4):465–77.